Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. Jul 24, 2022; 13(7): 616-629
Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.616
Figure 2
Figure 2 Prognostic value of the cellular morphometric biomarker signature. A: Multivariate Cox regression analysis with the hazard ratio (HR) represented as a forest plot for cellular morphometric biomarkers; B: Kaplan-Meier curves on overall survival for breast cancer patients are presented with respect to the cellular morphometric prognosis score (CMPS) groups; C: Multivariate Cox regression analysis with hazard ratio (HR) represented as a forest for CMPS groups, clinical factors, and PAM50 subtypes; D: Multivariate Cox regression analysis with the HR represented as a forest plot for CMPS, MAPS, and GEPS.